Sign in

CIK 0001824293

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

GRI Bio, Inc.

Sign in to watch
Ticker
GRI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
824369909
Phone
+1 619-400-1171
Business address
2223 AVENIDA DE LA PLAYA, SUITE 208, LA JOLLA, CA, 92037
Former names
Vallon Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-04 Baker David Charles Director Grant or award · Stock Option (Right to Buy) +3,935 3,935
2025-09-18 Baker David Charles Director Grant or award · Stock Option (Right to Buy) +23,605 23,605
2025-08-26 Baker David Charles Director Grant or award · Stock Option (Right to Buy) +5,994 5,994
2025-08-13 Baker David Charles Director Grant or award · Stock Option (Right to Buy) +4,527 4,527
2025-01-23 Baker David Charles Director Grant or award · Stock Option (Right to Buy) +30,297 $0.69 $21K 30,297
2023-08-10 Baker David Charles Director Grant or award · Stock Option (Right to Buy) +34,483 $2.90 $100K 34,483
2022-02-15 Baker David Charles Chief Executive Officer Grant or award · Stock Option (Right to Buy) +61,000 $5.63 $343K 61,000
2021-05-14 Baker David Charles Chief Executive Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2021-02-12 Baker David Charles Chief Executive Officer Other acquisition +7,843 $6.40 $50K 7,843
2021-02-12 Baker David Charles Chief Executive Officer Purchase +1,000 $8.00 $8K 8,843

Page 1 of 1 · 10 trades